Trident Lifeline Limited (BOM:543616)
India · Delayed Price · Currency is INR 272.25
+8.45 (3.20%)
At close: Aug 17, 2026
Trident Lifeline Revenue
Trident Lifeline had revenue of 337.18M INR in the quarter ending June 30, 2026, with 42.84% growth. This brings the company's revenue in the last twelve months to 1.39B, up 42.82% year-over-year. In the fiscal year ending March 31, 2026, Trident Lifeline had annual revenue of 1.29B with 48.36% growth.
Revenue (ttm)
1.39B
Revenue Growth
+42.82%
P/S Ratio
2.33
Revenue / Employee
n/a
Employees
74
Market Cap
3.25B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.29B | 420.57M | 48.36% |
| Mar 31, 2025 | 869.65M | 423.36M | 94.86% |
| Mar 31, 2024 | 446.29M | 129.36M | 40.82% |
| Mar 31, 2023 | 316.92M | 99.24M | 45.59% |
| Mar 31, 2022 | 217.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Albert David | 3.64B |
| Medico Remedies | 2.38B |
| Medicamen Biotech | 2.06B |
| Ambalal Sarabhai Enterprises | 1.99B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Astonea Labs | 1.48B |
| Oxygenta Pharmaceutical | 1.35B |